Botulinum Toxins Injections for Hypertonic Limbs—Is It So Effective?
A special issue of Toxins (ISSN 2072-6651). This special issue belongs to the section "Bacterial Toxins".
Deadline for manuscript submissions: 31 January 2025 | Viewed by 2602
Special Issue Editor
2. The Movement Disorders Clinic, Shaare Zedek Medical Center, Jerusalem 9103102, Israel
3. The School of Medicine, The Hebrew University, Jerusalem 91905, Israel
Interests: botulinum toxins
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Botulinum toxin (BT) is a widely recognized safe and effective treatment, routinely used for various medical conditions, including cervical dystonia (CD), hemifacial spasm (HFS) and blepharospasm. It is now also used to alleviate the upper and lower spasticity of the limbs. The evidence of its efficacy in the treatment of limb dystonia is even more scarce, primarily because it is not covered by insurance in most, if not all, countries. Furthermore, the treatment's effectiveness results have varied among studies. It is uncertain whether one hyperactive disorder of a limb is more responsive to BT than another. In contrast to BT treatment for CD, HFS, post-facial paralysis synkinesis or blepharospams, which was widely proved to be effective and safe, BT treatment for hyperactive limbs lack evidence relating its efficacy. In addition, the dropout rates are high for BT injections of hyperactive limbs, while compliance of BT for facial and cervical muscles is high.
This issue of Toxins is focused on BT treatment of spastic and dystonic limbs. The aim of this issue is to increase our knowledge on the efficacy of BT injections for hyperactive limbs, in order to optimize its efficacy.
Prof. Dr. Gilad Yahalom
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Toxins is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- botulinum
- spastic limb
- spasticity
- dystonic limb
- efficacy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.